Centre for Infectious Disease Research in Zambia
Centre for Infectious Disease Research in Zambia (CIDRZ, Zambia), is an independent non-profit non-governmental organisation that is committed to answering key research questions relevant to Zambia and the region. Established in 2001, CIDRZ provides a platform for coordinated development and deployment of state-of-the-art technologies and analyses, which can be utilized effectively for discovery, early development, and testing of clinical products. CIDRZ aims to improve access to quality healthcare in Zambia through innovative capacity development, exceptional implementation science and research and impactful and sustainable public health programmes. Over the years, the institution has positioned itself as the best health research institution in Zambia through conducting field and facility-based implementation science, and clinical trials which has enables the organisation generate impactful evidence and frequently informs policy to improving the quality of health care delivery in Zambia and beyond. CIDRZ collaborates with multiple global institutions and universities. Presently, CIDRZ is conducting 47 distinct studies and projects and is supported by a wide range of funders including, but not limited to the European & Developing Countries Clinical Trials Partnership (EDCTP), CDC-PEPFAR, UK-DFID, US NIH, Grand Challenge Research Fund (GCRF), Wellcome Trust, Bill & Melinda Gates Foundation and other philanthropies.
To assess the immunogenicity of three doses of increasing strength formulation of Shigella vaccine given at three time points in healthy Dutch and Burkinabe adults.